Pleural aspiration and pleural-fluid interpretation

01Purpose and principlesWhat the assessment is for and the core concepts behind it.

Pleural aspiration begins with indication and anatomy. A new unilateral effusion commonly requires diagnostic sampling unless the cause is already secure and aspiration would not alter care. Therapeutic aspiration assesses whether fluid removal improves breathlessness and can support decisions about recurrent or malignant effusion. Ultrasound is not an optional confirmation after choosing a site: it identifies the effusion in the patient's current position, distinguishes diaphragm and abdominal viscera, estimates depth and reveals septation or a small window. If no safe route exists, stop and obtain experienced image-guided help. The operator should be trained, use sterile technique and perform a documented pre-procedure check including antithrombotic medicines and a plan for unexpected deterioration.

Interpretation should be hypothesis-driven. Appearance is informative but not diagnostic: cloudy fluid may represent cells or lipid, blood staining may result from malignancy, embolism, trauma or the procedure, and an odour can support anaerobic infection. Light's criteria classify an exudate when pleural-fluid protein divided by serum protein exceeds 0.5, pleural-fluid LDH divided by serum LDH exceeds 0.6, or pleural-fluid LDH exceeds two-thirds of the laboratory upper reference limit for serum LDH. This sensitive classification can label a diuretic-treated cardiac effusion exudative. When the clinical picture strongly favours heart failure, serum-to-pleural gradients, natriuretic peptide and response to treatment may clarify the mechanism with specialist input.

Suspected pleural infection demands rapid pH handling. Frank pus is empyema and requires an infection drainage pathway. For non-purulent fluid, pH at or below 7.2 indicates high risk of complicated parapneumonic effusion or infection and supports drain insertion where fluid is accessible and the overall picture fits. Intermediate pH above 7.2 but below 7.4 requires integration with LDH, glucose, fever, fluid volume and septation; current BTS guidance highlights LDH above 900 IU/L among features that strengthen drainage consideration. pH at or above 7.4 lowers immediate infection-drainage likelihood but does not overrule worsening sepsis. Cytology, microbiology and targeted tests answer separate questions, and no biochemical pattern substitutes for clinical follow-up, repeat imaging or pleural biopsy when malignancy remains suspected.

Key points

Define whether aspiration is diagnostic, therapeutic or both, and whether the result will change drainage, antimicrobial, cancer or heart-failure management before inserting a needle.
Thoracic ultrasound must be used by a trained operator to confirm fluid, identify diaphragm and solid organs, and select a contemporaneous safe site; a remote skin mark is invalid after the patient moves.
Check consent, laterality, indication, observations, allergies, haemostasis and antithrombotic plan, patient positioning, asepsis, equipment, sample labels and rescue arrangements through the local checklist.
For suspected infection, send pleural fluid for pH promptly using the locally agreed blood-gas technique without air or local-anaesthetic contamination, alongside glucose, LDH, protein and microbiology.
Use paired serum protein and LDH to apply Light's criteria. Meeting any one criterion classifies the fluid as an exudate, but diuresed heart failure can be misclassified and requires clinical reconciliation.
Frank pus establishes empyema and does not need pH to justify drainage. In non-purulent suspected infection, pH at or below 7.2 indicates high risk and generally supports intercostal drainage if safely accessible.
Send an adequate cytology volume under local laboratory guidance and remember that negative cytology does not exclude pleural malignancy; tumour type and repeated sampling affect yield.
Drain therapeutic fluid slowly, generally limiting a single attempt to about 1.5 litres, and stop sooner if chest pain, tightness, persistent cough or worsening breathlessness develops.
Routine post-procedure chest radiography is not required after every straightforward, ultrasound-guided aspiration in an asymptomatic patient, but symptoms, air aspiration, difficulty or suspected complication change that decision.
Antithrombotic interruption, laboratory containers, pH handling, competence sign-off, drainage thresholds and referral routes must follow local UK policy and the latest BTS guidance.

02Indications, selection and cautionsWhen it is useful, when urgency changes and important limitations.

Complicated pleural infectionRed flag

Purulence, positive microbiology, pH at or below 7.2, low glucose, high LDH, loculation and ongoing sepsis support complicated parapneumonic effusion or empyema. Pus or high-risk non-purulent fluid generally needs timely drainage in addition to antimicrobial treatment.

Transudative mechanism

Bilateral or clinically typical effusions from heart failure, cirrhosis or hypoalbuminaemia often form through systemic pressure imbalance and fail all Light criteria. Unilateral dominance, fever, pleuritic pain, weight loss or poor response should reopen the differential.

Exudative mechanism

Meeting any Light criterion supports local pleural inflammation, impaired drainage or vascular injury, with infection, malignancy, pulmonary embolism and inflammatory disease among important causes. Exudate is a category for further investigation rather than a final diagnosis.

Malignant pleural concern

Recurrent unilateral exudate, pleural nodularity or thickening, weight loss and haemorrhagic fluid raise malignancy. Positive cytology can establish disease in some tumours, but a negative sample does not safely close the pathway when imaging and clinical suspicion persist.

Haemothorax patternRed flag

Uniformly bloody fluid after trauma, intervention or in a high-risk clinical setting requires paired pleural and peripheral haematocrit assessment and urgent specialist input. Do not dismiss progressive shock or falling haemoglobin as a traumatic tap.

Non-expandable lung

Failure of lung re-expansion, marked negative-pressure symptoms during drainage or a post-aspiration hydropneumothorax without clinical tension can reflect trapped or entrapped lung. Further suction or repeated aspiration may worsen symptoms and needs pleural-specialist review.

03Method and interpretationA systematic approach to the test and its findings.

Investigation order

Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.

01
Thoracic ultrasoundFirst step
Why
Confirm the presence, depth and accessibility of pleural fluid, identify septation and prevent injury to diaphragm, lung and abdominal organs.
Interpretation and limitations
Scan in the intended procedure position immediately before needle entry and save or document findings under governance. No safe window, very shallow fluid or complex anatomy is a reason to stop and seek experienced image-guided intervention.
02
Paired pleural and serum protein and LDH
Why
Apply Light's criteria to classify the effusion as exudative or transudative and direct the aetiological work-up.
Interpretation and limitations
Any positive Light criterion makes an exudate. Check units and the laboratory serum-LDH upper reference limit; if diuresed heart failure is clinically compelling despite an exudative label, use additional cardiac assessment rather than ignoring discordance.
03
Pleural-fluid pH
Why
Risk-stratify a non-purulent parapneumonic effusion and determine whether infection-related drainage should be pursued.
Interpretation and limitations
Collect promptly in the laboratory-approved heparinised blood-gas syringe, exclude air and local anaesthetic, and analyse without delay. At or below 7.2 supports drainage when safely possible; intermediate values require LDH, glucose, imaging and clinical context.
04
Pleural glucose and LDH
Why
Support infection risk assessment when pH is unavailable or intermediate and identify high pleural inflammatory activity.
Interpretation and limitations
Low glucose and high LDH strengthen infection concern but also occur in malignancy and inflammatory pleuritis. In intermediate-pH infection, LDH above 900 IU/L and adverse clinical or imaging features support drainage consideration under BTS guidance.
05
Pleural microbiology
Why
Identify organisms and guide antimicrobial narrowing in suspected infection.
Interpretation and limitations
Send a sterile-container sample and inoculate appropriate blood-culture bottles at the bedside according to local microbiology instructions. Prior antibiotics reduce yield; negative culture does not exclude pleural infection when biochemistry and sepsis support it.
06
Pleural cytology
Why
Detect malignant cells and, where possible, provide cell block material for tumour typing and molecular assessment.
Interpretation and limitations
Send the locally required volume promptly; BTS advises 25 to 50 mL where feasible for initial assessment. Sensitivity varies by tumour, so negative cytology with persistent concern leads to respiratory or pleural multidisciplinary review and possible tissue biopsy.
07
Targeted pleural tests
Why
Investigate specific alternatives such as chylothorax, pancreatitis-related effusion, oesophageal rupture, tuberculosis or haemothorax when history and appearance support them.
Interpretation and limitations
Request triglyceride and cholesterol, amylase, mycobacterial studies or paired haematocrit selectively and after discussion with the laboratory or specialist. Untargeted panels consume small samples and can generate misleading borderline results.
08
Post-procedure imaging
Why
Assess suspected pneumothorax, bleeding, malposition or failure of lung expansion after a difficult or symptomatic procedure.
Interpretation and limitations
Do not order routine radiography solely because aspiration occurred when ultrasound guidance was straightforward and the patient remains asymptomatic. New pain, dyspnoea, hypoxaemia, air aspiration, multiple attempts or clinical concern justifies immediate reassessment and imaging.

04Clinical next stepsHow the result changes management or prompts escalation.

01PreparationProve indication and safe accessFirst stepDiagnostic or therapeutic pleural aspiration is being considered.

1Review imaging and define what aspiration will decide, assess urgency and alternatives, and obtain informed consent covering pain, bleeding, infection, organ injury, pneumothorax and failure to obtain an answer.
2Check observations, laterality, allergies, antithrombotic medicines and relevant haemostasis under local policy, while recognising that urgent sepsis may require an individual risk decision.
3Position the patient safely, perform contemporaneous thoracic ultrasound, identify diaphragm and viscera, and abandon bedside aspiration if no safe accessible pocket exists.
4Complete the local checklist with sterile equipment, labels, sample containers, monitoring and a plan for deterioration before skin preparation.

02ProcedureAspirate deliberately and slowlyA safe ultrasound-defined site and valid indication have been confirmed.

1Use aseptic technique and locally approved local anaesthesia, maintaining needle control over the superior rib margin and aspirating as the pleural space is approached.
2For diagnostic sampling, obtain enough fluid for the pre-planned tubes without repeatedly manipulating the needle; prioritise time-sensitive pH and microbiology when infection is suspected.
3For therapeutic aspiration, use controlled manual or gravity drainage, observe symptoms and physiology, and generally stop by 1.5 litres in one attempt or earlier for pain, tightness, persistent cough or dyspnoea.
4Remove the device safely, apply a dressing, label specimens at the bedside and document side, ultrasound, volume, appearance, tolerance and any complication.

03InfectionTranslate pH into drainage actionPneumonia, fever or sepsis accompanies a pleural effusion.

1If fluid is frank pus, treat as empyema, send microbiology and arrange prompt small-bore drain and antimicrobial management with respiratory or pleural specialists.
2If non-purulent, obtain uncontaminated prompt pH; at or below 7.2, pursue drainage when safely accessible and clinically appropriate.
3For pH above 7.2 but below 7.4, integrate LDH, glucose, persistent fever, collection size, pleural enhancement and septation; adverse features strengthen the drainage decision.
4If immediate drainage is not selected, document a tight reassessment plan with clinical observations, inflammatory trajectory and repeat ultrasound because pleural infection can evolve.

04Unexplained exudateContinue beyond negative cytologyLight's criteria show an exudate and infection or malignancy remains unresolved.

1Revisit history for cancer, embolic, inflammatory, drug, occupational and tuberculosis risks, and review contrast CT with an experienced radiologist.
2Check cytology adequacy and tumour-specific yield, then discuss repeat sampling, image-guided pleural biopsy or thoracoscopy rather than repeatedly sending low-value small specimens.
3Refer through the relevant lung-cancer, pleural or infection pathway, communicate uncertainty to the patient and nominate the clinician responsible for every outstanding result.
4DefinitiveProvide a plan for recurrent breathlessness and consider definitive fluid-control options only after lung expandability, diagnosis, prognosis and patient preference are assessed.

05AftercareDetect complications and close resultsAny diagnostic or therapeutic pleural aspiration has finished.

1Reassess breathing, pain, SpO2, pulse and blood pressure, inspect the site and ask specifically about new chest tightness, cough or dyspnoea.
2Arrange prompt imaging and senior review for symptoms, air aspiration, procedural difficulty, suspected bleeding or physiological change; uncomplicated asymptomatic aspiration does not mandate routine radiography.
3Track pH, microbiology, cytology and biochemistry to a named reviewer, communicate urgent results directly and reconcile the complete pattern with imaging.
4Document the diagnosis, uncertainty, follow-up and safety-netting, including whom the patient should contact if breathlessness, fever, bleeding or pain worsens.

05Procedure and medicine safetyRelevant preparation, treatment and contraindications.

Provides procedural analgesia and improves the patient's ability to remain safely positioned during needle entry and fluid aspiration.

Local anaesthetic for pleural aspiration

Infiltrate skin, subcutaneous tissue and periosteal tissues using the locally approved agent, concentration and maximum weight-adjusted limit, aspirating before incremental administration.

Calculate the maximum permitted amount before starting, include anaesthetic already used by others, avoid intravascular injection and pleural-fluid contamination, and know the local toxicity-rescue protocol.

06Risks, monitoring and follow-upComplications, safety checks and further assessment.

Record baseline and post-procedure respiratory rate, SpO2 and oxygen device, pulse, blood pressure, pain and breathlessness, with closer observation for a frail or unstable patient.
During therapeutic drainage, track cumulative volume, rate, symptoms and fluid appearance; stop immediately for chest tightness, persistent cough, pain, worsening dyspnoea or physiological decline.
Check the puncture site and haemoglobin or imaging when bleeding is clinically suspected, particularly in patients with altered haemostasis.
Review pH immediately, microbiology as it becomes available and cytology or biochemistry through a results system that assigns a named clinician.
Repeat clinical assessment and ultrasound when pleural infection is managed without immediate drainage or when fluid reaccumulates, rather than relying on the first sample indefinitely.
Monitor completion of cancer, pleural-clinic or biopsy referral after a negative cytology result that does not resolve radiological concern.

07Special situationsVariants, exceptions and circumstances that change the usual approach.

Light favours sensitivity

Light's criteria are deliberately sensitive for exudates, so a diuretic-concentrated cardiac effusion may cross a threshold. Discordance calls for additional cardiac reasoning, not casual relabelling or abandonment of the clinical picture.

pH is pre-analytical

Air exposure, local anaesthetic contamination, excess heparin and delayed analysis can alter pleural pH enough to change a drainage decision. Correct collection and rapid transport are clinical safety tasks.

Purulence outranks pH

Frank pus already establishes empyema physiology and needs a drainage pathway. Sending it for pH can delay action and a numerical value cannot make purulent infection uncomplicated.

Negative cytology is conditional

Cytological sensitivity depends strongly on tumour type and sample adequacy. Mesothelioma and some other pleural tumours often require tissue, so persistent pleural thickening or nodularity should progress to specialist biopsy planning.

Post-aspiration air varies

A hydropneumothorax after fluid removal may represent visceral puncture, air entry or non-expandable lung. Symptoms, imaging pattern and pressure behaviour determine whether observation, drainage or specialist review is appropriate.

Ultrasound is time specific

Fluid and organs move with position and respiration. A safe site marked in one posture is not transferable after the patient sits, lies down or twists, which is why the procedural scan must be contemporaneous.

08Common pitfallsFrequent interpretation and management errors.

01
Performing aspiration from a radiograph or an old ultrasound mark without scanning the patient in the current procedural position.
02
Contaminating the pleural pH sample with local anaesthetic or air and then using the distorted value to decide drainage.
03
Calling any Light-positive effusion infection instead of treating exudate as a broad mechanistic category.
04
Dismissing a diuresed heart-failure effusion because it narrowly fulfils an exudative criterion without reconciling the full picture.
05
Continuing rapid therapeutic drainage through persistent cough or chest tightness and exceeding a safe symptom-led endpoint.
06
Interpreting negative cytology as exclusion of malignancy despite pleural nodularity, recurrence or high-risk symptoms.
07
Ordering routine post-aspiration radiography while failing to image the patient who has new pain, hypoxaemia or dyspnoea.
08
Sending samples without a named results owner, allowing a positive culture or malignant cytology report to remain unactioned.